| BMN 673 (8R,9S) |
(8R,9S)-5-氟-8-(4-氟苯基)-2,7,8,9-四氢-9-(1-甲基-1H-1,2,4-三唑-5-基)-3H-吡啶并[4,3,2-DE]酞嗪-3-酮 |
1207456-00-5 |
| N-(5-(4-(bromomethyl)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide |
N-[5(4-溴甲基苯基)-[1,2,4]三氮唑并[1,5-A]吡啶-2-基)环并甲酰胺 |
1206163-59-8 |
| 8H-7,10-Methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylic acid, 5-(1,1-diMethylethyl)-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-14-Methoxy-3,6-dioxo-, Methyl ester, (1aR,5S,8S,10R,22aR)- |
MK-5172 中间体 |
1206524-84-6 |
| AMG 232 |
2-((3R,5R,6S)-5-(3-氯苯基)-6-(4-氯苯基)-1-((S)-1-(异丙基磺酰基)-3-甲基丁烷-2-基)-3-甲基-2-氧代哌啶-3-基)乙酸 |
1352066-68-2 |
| N,N',N"-[boroxin-2,4,6-triyltris[[(1R)-3-methylbutane-1,1-diyl]imino(2-oxoethane-2,1-diyl)] ]tris(2,5-dichlorobenzamide) |
N,N',N''-[BOROXIN-2,4,6-TRIYLTRIS[[(1R)-3-METHYLBUTANE-1,1-DIYL]IMINO(2-OXOETHANE-2,1-DIYL)] ]TRIS(2,5-DICHLOROBENZAMIDE) |
1201903-03-8 |
| GSK299423 |
化合物 T32008 |
1352149-24-6 |
| AvibactaM |
AvibactaM |
1192500-31-4 |
| 6-chloro-4-(MorpholinoMethyl)pyridin-2-aMine |
6-chloro-4-(MorpholinoMethyl)pyridin-2-aMine |
1334294-43-7 |
| 4-(2-fluoro-4-nitrophenyl)-1-methyl-1,4,5,6-tetrahydro-1,2,4-triazine |
4-(2-氟-4-硝基 - 苯基)-1-甲基-5,6-二氢-1,2,4-三嗪 |
1334167-66-6 |
| TAK-931 |
TAK 931 |
1330782-76-7 |
| (S)-4-Bromo-2,3-dihydro-1H-inden-1-amine hydrochloride |
(S)-4-溴-2,3-二氢-1H-茚-1-胺盐酸盐 |
1307873-37-5 |
| CPD1332, 3744-A2` |
CPD1332, 3744-A2` |
1307873-35-3 |
| LHW090-A7 |
(ALPHAS)-3'-氯-ALPHA-[[(1S)-2-乙氧基-1-甲基-2-氧代乙基]氨基][1,1'-联苯]-4-丙酸 |
1308256-94-1 |
| (3S,4R)-tert-Butyl 3-amino-4-fluoropiperidine-1-carboxylate |
(3S,4R)-3-氨基-4-氟哌啶-1-甲酸叔丁酯 |
1290191-73-9 |
| SAR-020106 |
SAR-020106 |
1184843-57-9 |
| 8-Chloroisoquinolin-3-aMine |
8-氯异喹啉-3-胺 |
1184843-26-2 |
| 3,8-dichloroisoquinoline |
1184843-27-3 |
1184843-27-3 |
| PX 102 |
CPD1220 |
1268245-19-7 |
| Px-104 |
PX-20606手性 |
1268244-88-7 |
| PX20606 trans-isomer |
CPDD1220反式消旋体 |
1268244-85-4 |
